A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Automated insulin delivery (AID) significantly improved glycemic control in type 2 diabetes patients compared to continuous glucose monitoring (CGM) alone. This randomized trial demonstrated reduced glycated hemoglobin levels and increased time in target glucose range with AID.
Area Of Science
- Endocrinology
- Metabolic Diseases
- Medical Technology
Background
- Automated insulin delivery (AID) systems show promise for type 1 diabetes management.
- Limited data exist from randomized controlled trials on AID for insulin-treated type 2 diabetes.
Purpose Of The Study
- To evaluate the efficacy of AID in adults with insulin-treated type 2 diabetes.
- To compare AID with continuous glucose monitoring (CGM) alone in managing type 2 diabetes.
Main Methods
- A 13-week, multicenter, randomized controlled trial.
- Adults with insulin-treated type 2 diabetes were assigned to AID or a control group using their usual insulin delivery method.
- Both groups utilized continuous glucose monitoring (CGM).
Main Results
- The AID group experienced a greater reduction in glycated hemoglobin (HbA1c) levels (-0.9% vs. -0.3%).
- Time in target glucose range (70-180 mg/dL) significantly increased in the AID group (64% vs. 52%).
- Hyperglycemia-related CGM outcomes improved with AID; hypoglycemia rates were low in both groups.
Conclusions
- Automated insulin delivery (AID) is more effective than CGM alone for improving glycemic control in insulin-treated type 2 diabetes.
- AID offers a significant benefit for managing type 2 diabetes, warranting further investigation.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...